India: New patent law may restrict access to HIV/AIDS treatments.
On 4 April 2005, India's Patents (Amendment) Act, 2005 (the Act) received presidential assent. The Act, which represents a major shift in Indian patent policy, raises serious concerns that the supply of generic drugs to developing countries could decline.
Cruess
Gord
G
D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006801:Humans; D007194:India; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
D019380:Anti-HIV Agents; D016568:Drugs, Generic